198 related articles for article (PubMed ID: 12297404)
1. Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK.
Hoshino Y; Jones RW; Chanock RM; Kapikian AZ
Vaccine; 2002 Oct; 20(29-30):3576-84. PubMed ID: 12297404
[TBL] [Abstract][Full Text] [Related]
2. Construction and characterization of rhesus monkey rotavirus (MMU18006)- or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines.
Hoshino Y; Jones RW; Ross J; Kapikian AZ
Vaccine; 2003 Jun; 21(21-22):3003-10. PubMed ID: 12798644
[TBL] [Abstract][Full Text] [Related]
3. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity.
Hoshino Y; Jones RW; Chanock RM; Kapikian AZ
J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947
[TBL] [Abstract][Full Text] [Related]
4. Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: construction and characterization.
Hoshino Y; Jones RW; Ross J; Kapikian AZ
Vaccine; 2005 May; 23(29):3791-9. PubMed ID: 15893616
[TBL] [Abstract][Full Text] [Related]
5. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine.
Kapikian AZ; Hoshino Y; Chanock RM; Perez-Schael I
Arch Virol Suppl; 1996; 12():163-75. PubMed ID: 9015113
[TBL] [Abstract][Full Text] [Related]
6. Serotypic characterization of outer capsid spike protein VP4 of vervet monkey rotavirus SA11 strain.
Hoshino Y; Jones RW; Kapikian AZ
Arch Virol; 1998; 143(6):1233-44. PubMed ID: 9687880
[TBL] [Abstract][Full Text] [Related]
7. Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.
Kanai Y; Onishi M; Kawagishi T; Pannacha P; Nurdin JA; Nouda R; Yamasaki M; Lusiany T; Khamrin P; Okitsu S; Hayakawa S; Ebina H; Ushijima H; Kobayashi T
J Virol; 2020 Dec; 95(2):. PubMed ID: 33087468
[TBL] [Abstract][Full Text] [Related]
8. Characterization of neutralization specificities of outer capsid spike protein VP4 of selected murine, lapine, and human rotavirus strains.
Hoshino Y; Jones RW; Kapikian AZ
Virology; 2002 Jul; 299(1):64-71. PubMed ID: 12167342
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3.
Hoshino Y; Jones RW; Ross J; Honma S; Santos N; Gentsch JR; Kapikian AZ
J Virol; 2004 Jul; 78(14):7795-802. PubMed ID: 15220453
[TBL] [Abstract][Full Text] [Related]
10. Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.
Gorziglia M; Larralde G; Kapikian AZ; Chanock RM
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7155-9. PubMed ID: 1698292
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children.
Kapikian AZ; Hoshino Y; Chanock RM; Pérez-Schael I
J Infect Dis; 1996 Sep; 174 Suppl 1():S65-72. PubMed ID: 8752293
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus vaccines: an overview.
Midthun K; Kapikian AZ
Clin Microbiol Rev; 1996 Jul; 9(3):423-34. PubMed ID: 8809469
[TBL] [Abstract][Full Text] [Related]
13. Identification of four VP4 serological types (P serotypes) of bovine rotavirus using viral reassortants.
Snodgrass DR; Hoshino Y; Fitzgerald TA; Smith M; Browning GF; Gorziglia M
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2319-25. PubMed ID: 1328488
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
[TBL] [Abstract][Full Text] [Related]
15. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception.
Kapikian AZ; Simonsen L; Vesikari T; Hoshino Y; Morens DM; Chanock RM; La Montagne JR; Murphy BR
J Infect Dis; 2005 Sep; 192 Suppl 1():S22-9. PubMed ID: 16088801
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the VP7, VP4, VP6, NSP4, and NSP5/6 genes of a buffalo rotavirus strain: identification of the rare P[3] rhesus rotavirus-like VP4 gene allele.
Martella V; Ciarlet M; Pratelli A; Arista S; Terio V; Elia G; Cavalli A; Gentile M; Decaro N; Greco G; Cafiero MA; Tempesta M; Buonavoglia C
J Clin Microbiol; 2003 Dec; 41(12):5665-75. PubMed ID: 14662959
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS-1 x UK) (P1A[8],G2).
Eichelberger MC; Sperber E; Wagner M; Hoshino Y; Dudas R; Hodgins V; Marron J; Nehring P; Casey R; Burns B; Karron R; Clements-Mann ML; Kapikian AZ
J Med Virol; 2002 Mar; 66(3):407-16. PubMed ID: 11793395
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
19. Molecular and serologic characterization of novel serotype G8 human rotavirus strains detected in Blantyre, Malawi.
Cunliffe NA; Gentsch JR; Kirkwood CD; Gondwe JS; Dove W; Nakagomi O; Nakagomi T; Hoshino Y; Bresee JS; Glass RI; Molyneux ME; Hart CA
Virology; 2000 Sep; 274(2):309-20. PubMed ID: 10964774
[TBL] [Abstract][Full Text] [Related]
20. Human rotavirus strains bearing VP4 gene P[6] allele recovered from asymptomatic or symptomatic infections share similar, if not identical, VP4 neutralization specificities.
Hoshino Y; Jones RW; Ross J; Santos N; Kapikian AZ
Virology; 2003 Nov; 316(1):1-8. PubMed ID: 14599785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
